Reimbursement & Market Access

Strategic analysis of dual CE Mark + FDA 510(k)/PMA approval showing the multiplier effect across 25+ markets, country grouping matrix, and concrete cost/timeline comparisons for manufacturers pursuing both pathways.

A strategic map of 25+ countries where CE marking provides regulatory leverage — organized by mechanism: full reliance, abridged review, evidence-only acceptance, and reference-only. Know which markets your CE Mark unlocks and what extra steps remain.

Busting the two biggest myths about Indonesian medical device registration — which devices actually need BPJPH Halal certification (not all of them), and whether CDAKB is a foreign manufacturer obligation or a local distributor obligation.

A narrow operational guide to transferring your Authorized Representative under the Saudi SFDA MDMA system — step-by-step process, 2026 fee schedule, multi-AR rules, and escalation options when your current AR refuses to cooperate.

Everything you need to know about registering medical devices in South Africa in 2026 — including SAHPRA requirements, establishment licensing, classification (Class A–D), ISO 13485 mandates, reliance pathways, Authorized Representative obligations, fees, and step-by-step registration instructions.

Everything you need to know about registering medical devices in Taiwan in 2026 — including TFDA requirements, the Medical Devices Act, classification (Class I–III), QSD certification, local agent obligations, UDI requirements, fees, timelines, and step-by-step registration instructions.

Everything you need to know about registering medical devices in Turkey in 2026 — including TITCK requirements, EU MDR/IVDR alignment, classification (Class I–III), UTS electronic registration, Authorized Representative obligations, fees, timeline, and step-by-step registration instructions.

How Brazil's SUS public healthcare system procures medical devices — covering the legal framework (Law 14,133/2021), CONITEC health technology assessment, e-procurement via Compras.gov.br, requirements for foreign suppliers, pricing mechanisms, and strategic recommendations for market entry.

How Germany procures and reimburses medical devices through the GKV statutory health insurance system — G-DRG case-based payments, NUB innovative device pathway, Hilfsmittelverzeichnis medical aids, DiGA digital health applications, GPO group purchasing, hospital tendering, BfArM registration, and practical strategies for foreign manufacturers entering Europe's largest medical device market.

How India procures medical devices through government channels — GeM Government e-Marketplace platform, Make in India (MII) local content requirements, CGHS and PM-JAY reimbursement schemes, HLL Medical Services procurement, CDSCO and BIS registration, tendering procedures, and practical strategies for foreign manufacturers entering India's rapidly growing medical device market.

How Indonesia procures medical devices through the e-Katalog electronic catalog system — Ministry of Health sectoral e-Katalog management, INAPROC Version 6 migration, JKN/BJPS Kesehatan national insurance reimbursement, TKDN domestic content requirements, BPOM/MoH registration, CDAKB distributor certification, and practical strategies for foreign manufacturers entering Southeast Asia's largest medical device market.

Navigate Japan's National Health Insurance system for medical devices — NHI pricing structure, STM vs. non-STM reimbursement, DPC bundling, hospital tendering, and foreign supplier requirements for the world's third-largest device market.

How Nigeria procures medical devices through the NHIA insurance system, the new Medipool national GPO, Bureau of Public Procurement tendering, NAFDAC device registration, the BHCPF fund, PVAC local manufacturing initiative, and practical strategies for foreign suppliers entering Africa's largest medical device import market.

How to navigate Saudi Arabia's NUPCO centralized procurement system for medical devices — including framework tenders, SFDA registration, localization requirements, Wasfaty integration, and practical strategies for foreign manufacturers entering the Kingdom's $2-3 billion medical device market.

How South Korea procures and reimburses medical devices through the National Health Insurance Service (NHIS) — including MFDS approval, HIRA reimbursement listing, NECA health technology assessment, the new Immediate Market Entry pathway, pricing and payment mechanisms, and strategies for foreign manufacturers entering Korea's $7.5 billion medical device market.

How Thailand's government procures medical devices through the National Health Security Office (NHSO), e-Market and e-Bidding electronic procurement, the Universal Coverage Scheme, Thai FDA regulatory requirements, Innovation List procurement preferences, and practical strategies for foreign manufacturers entering Thailand's $2.2 billion medical device market.

How the US government and hospital systems procure medical devices — GPO group purchasing organizations (Vizient, Premier, HealthTrust), VA Federal Supply Schedules, DoD procurement, GSA Schedule contracts, SAM.gov registration, and practical strategies for medical device manufacturers seeking to enter the US public-sector supply chain.

Everything you need to know about the ASEAN Medical Device Directive (AMDD) and Common Submission Dossier Template (CSDT) in 2026 — including harmonized classification (Class A–D), CSDT sections and preparation, member state implementation status, regulatory reliance pathways, Singapore–Malaysia pilot, fees, timelines, and step-by-step guidance for multi-country ASEAN market entry.

Everything you need to know about Bureau of Indian Standards (BIS) certification for medical devices in India in 2026 — including which devices require BIS, applicable IS standards, ISI mark, registration schemes for Indian and foreign manufacturers, Manakonline portal, testing in BIS-recognized labs, relationship with CDSCO, costs, timelines, and step-by-step guidance.

Everything you need to know about ANMAT medical device registration in Argentina — covering classification (Classes I–IV), Declaration of Conformity vs full review pathways, HELENA submission system, fees, timelines, authorized representative requirements, GMP compliance, and 2026 regulatory updates.